Rybelsus and Eye Health

Clinical trials with semaglutide showed that some patients with existing diabetic retinopathy had early worsening soon after starting therapy. The effect appears to relate to how quickly A1C improves rather than a direct toxic effect. Patients with retinopathy need closer monitoring when glucose control improves rapidly.

Who is at higher risk for early worsening?

• Pre-existing moderate to severe retinopathy or any macular edema
• High baseline A1C, for example above 9 to 10 percent
• Large and rapid A1C drop, for example more than about 2 percentage points within 3 months
• Long duration of diabetes and insulin use
• Concurrent uncontrolled hypertension, kidney disease, or high lipids

Most of this worsening happens within the first six to twelve months of treatment. We plan more frequent retinal checks during this period and treat promptly if changes appear. The long-term benefits of good blood sugar control usually outweigh this early risk.

Many patients notice their vision becomes blurry or unstable when they start Rybelsus or increase their dose. This happens because the lens in your eye changes shape as your blood sugar levels stabilize at lower numbers. Avoid driving or high-risk tasks if your vision is fluctuating.

• Blurriness typically begins within the first few weeks
• Vision may fluctuate from day to day or even hour to hour
• Blur may switch between distance and near as your prescription shifts
• Reading and focusing on close objects often becomes harder
• Symptoms usually improve after four to eight weeks
• Getting new glasses during this time is generally not helpful

Some patients report dry eye symptoms while on GLP-1 medications. This may be related to dehydration or other common causes rather than a direct drug effect. Symptoms can include dryness, irritation, or a gritty feeling in the eyes.

If you notice dryness or discomfort, these steps can help.

• Use preservative-free artificial tears up to 4 to 6 times daily
• Stay well hydrated, especially if you have nausea or vomiting
• Warm compresses and lid hygiene can help if your eyelids are oily or inflamed
• Contact our office for persistent pain, light sensitivity, or reduced vision

Rybelsus by itself rarely causes low blood sugar, but lows are more likely if you also take insulin or a sulfonylurea. Hypoglycemia can cause temporary blurred vision, dimness, or dizziness.

• Ask your diabetes doctor whether insulin or sulfonylurea doses should be reduced when starting Rybelsus
• Check glucose before driving and avoid driving if your vision is unstable
• Treat lows promptly and recheck vision after glucose normalizes
• Let us know if you are having frequent hypoglycemia

Besides blurriness and dryness, you may notice other changes in your vision while taking Rybelsus. If you experience any of the following symptoms, contact our office rather than waiting to see if they resolve on their own.

• New wavy or distorted lines when you read
• A gray or dark spot in the center of vision
• Halos around lights with headache, eye pain, or nausea
• Color vision changes or trouble adapting to light

The best outcomes happen when your diabetes care team and eye doctor communicate regularly about your treatment plan. We encourage you to sign release forms so your doctors can share test results and coordinate the timing of medication changes.

• Share your eye exam reports with your diabetes doctor
• Tell us whenever your diabetes medications or insulin doses change
• Bring a current medication list to every eye appointment
• Let both providers know if you experience new symptoms

Research suggests that slower, more gradual reductions in A1C may lower the risk of early retinopathy worsening. Your diabetes doctor might choose to start Rybelsus at a lower dose and increase it slowly, or they may adjust other medications to avoid sudden drops in blood sugar. While everyone wants to see A1C improve quickly, a gentler approach over several months can be safer for your eyes. If you already have diabetic retinopathy, we try to avoid A1C reductions greater than about 2 percentage points over the first three months when possible, and we increase eye monitoring during this period.

If we detect significant retinopathy or macular swelling before you begin Rybelsus, we may recommend treating those problems first. Early intervention with laser therapy or eye injections can stabilize your retina and reduce the chance of worsening during the initial treatment phase. Delaying Rybelsus for a few weeks or months to address existing eye disease does not mean you cannot take the medication safely. It simply allows us to optimize your eye health before your blood sugar begins to improve rapidly.

Beyond taking your medications and attending regular eye exams, simple daily habits can help protect your vision. Keeping your blood pressure and cholesterol under control is just as important as managing blood sugar for preventing diabetic eye disease.

• Take all your diabetes medications exactly as prescribed
• Monitor your blood sugar regularly and report patterns to your diabetes team
• Eat a balanced diet rich in vegetables, fruits, and whole grains
• Exercise most days of the week as your doctor recommends
• Avoid smoking, which significantly increases retinopathy risk

In select situations we may coordinate with your diabetes doctor to adjust the timing or choice of therapy. Patients with advanced proliferative diabetic retinopathy or very unstable vision may benefit from alternative medications that allow for slower blood sugar improvement. Alternatives can include SGLT2 inhibitors, DPP-4 inhibitors, basal insulin, or other regimens as appropriate. This decision is highly individual and depends on the severity of your eye disease, how well your diabetes is currently controlled, and what other medication options are available. We rarely avoid GLP-1 therapy solely because of eye concerns, and more often we increase monitoring and treat eye disease proactively.